The #SANBioLabHack2018 took place in Pretoria, South Africa, this week with 17 undergraduate students coming together to turn their passion for innovation by addressing afro-centric solutions to common lab issues.
The Department of Science and Technology (DST) Director General, Phil Mjwara announced the Southern Africa Network for Biosciences (NEPAD SANBio) as one of the new models of international cooperation to address SA’s key biosciences priority issues in health and nutrition.
We would like to introduce to you Professor Olubukola Babalola, the Director for the Food Security and Safety Niche area and the Principal Investigator Department of Microbial Laboratory at the NWU Mafikeng Campus. We are glad she also participated in the SANBio Annual Event in February 2017 as a speaker.
Rare diseases, cell culture technologies, clinical challenges and support platforms
Reducing CAPEX investments, raising funds, and linkages to universities
Intellectual property, regulations, and attorney fees
Boston, an area of 124 square kilometres has a remarkably large number of attorney firms with new firms established frequently. One would wonder how so many lawyers could be established in such a small space and still be profitable, but when one looks deeper into the Boston biotech ecosystem, the reasons become rather obvious. This is because in an area of just over 124 square kilometres, there are at least 900+ companies with some big brands such as Vertex established here.
Introduction: A view into the Boston Biotech and Biomedical Landscape
NEPAD SANBio, with support from the BioFISA II Programme, hosted their Annual Event on 21-22 February 2017 at the OR Tambo Conference Centre in Boksburg, South Africa. The theme of the event was Business meets Biosciences.
An acceleration programme aimed at supporting women in biosciences was launched on 21 February 2017, during the SANBio Annual Event 2017, by the NEPAD Southern Africa Network for Biosciences (SANBio) with support from the BioFISA II programme.
SANBio is a platform for shared biosciences research, development and innovation to address health and nutrition issues of Southern Africa and it is hosted by the Council for Scientific and Industrial Research (CSIR) in South Africa.
A project receiving funding from the NEPAD Southern Africa Network for Biosciences / BioFISA II Programme, entitled Gene Dose EFV was awarded the 1st place award in GAP Biosciences/Medical Innovations at the recent Gauteng Acceleration Programme (GAP) event which was held in South Africa Gauteng on 17 November 2016.